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Skin cancer is the most prevalent human malignancy and is primarily caused by 
ultraviolet (UV) wavelengths of sunlight. However, the fact that most skin cancers occur 
in people over the age of 60 indicates that advantaged age is a second skin cancer risk 
factor. Why geriatric skin is prone to developing skin cancers is not clear, but several 
studies have shown that dermal fibroblasts in geriatric skin express lower levels of the 
hormone insulin-like growth factor-1 (IGF-1) than young adult skin and that deficient 
IGF-1 signaling negatively impacts how epidermal keratinocytes respond to UVB 
radiation. A major regulator of the cellular response to UVB-induced DNA damage 
response is the tumor suppressor protein p53, and a previous study indicated that p53 is 
not properly activated in UVB-irradiated human keratinocytes deficient in IGF-1 
signaling. Using cultured human keratinocytes in vitro, we show here that several 
downstream transcriptional targets of p53, including the cell cycle-dependent kinase 
inhibitor p21, the translesion synthesis polymerase pol eta, and the DNA repair factors 
XPC and DDB, are not properly induced following UVB exposure in cells deprived of 
iv 
 
IGF-1. Using discarded human skin from routine panniculectomies, we show that the 
topical application of an IGF-1 receptor antagonist similarly abrogates the ability of UVB 
exposure to properly induce pol eta and p21. Because these various p53 target gene 
products are involved in delaying entry into S phase, accurately replicating UVB 
photoproducts, and removing UVB photoproducts from genomic DNA, our findings 
indicate that the inability of IGF-1-deficient geriatric skin properly activate p53-response 
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Non-melanoma skin cancer (NMSC) is the most common type of cancer 
worldwide and the fifth most expensive cancer to treat. Non-melanoma skin cancer has a 
high rate of incidence compared to melanoma skin cancer, that is, around 18 to 20 times 
more common than melanoma skin cancer. In the United States of America, each year 
around 5 million Americans are treated for skin cancer with an associated cost of around 
$8.1 billion. Moreover, NMSC is correlated with geriatric people because most of NMSC 
occur in people over 60 years. Previous studies have indicated that the activation status of 
the insulin-like growth factor-1 receptor (IGF-1R) in keratinocytes in geriatric skin is one 
factor that may contribute to NMSC development. The activation of IGF-1R in epidermal 
keratinocytes is dependent on the production of IGF-1 by dermal fibroblasts. 
Furthermore, the activation status of IGF-1R plays a significant role in the production of 
p53 target genes such as pol eta and p21. The importance of pol eta is to avoid the 
stalling of replication forks during the replication process and is mutated in patients who 
suffer from a variant form of xeroderma pigmentosum (XPV). Though pol eta is known 
to contribute to mutagenesis, it has not been a widely studied in keratinocytes or human 
skin. The p21 is important for cell cycle arrest and gives cells more time to repair the 
damage in genetic materials. The motivation for these studies was to define a potential 





 The research reported in this thesis is to understand the impact of insulin-like 
growth factor 1 in the activation of p53 target genes in keratinocytes in vitro and human 
skin ex vivo. I focused on two important proteins which are polymerase eta and p21. 
Polymerase eta is necessary for bypassing the UVB-induced thymine dimers during DNA 
replication to avoid any stalling of replication forks, and it is important to understand 
what could happen while pol eta is absent or inhibited due to a lack of IGF-1. The 
p21protein is important to understand its role while the IGF-1R is inactive. I examined 
the induction of these two significant proteins in UVB-irradiated keratinocytes and skin 
epidermis, which could help to elucidate potential mechanisms by which geriatric skin is 
prone to skin carcinogenesis.   
Thesis Organization 
 In chapter 1, I provide some background about the most important topics in my 
research area. This brief background is to make my idea clear and understandable and to 
provide the rationale for choosing this topic. Moreover, I discuss published articles to 
support my idea as well. In chapter 2, I present my results by using different model 
systems. I start by using N-TERTs keratinocytes in vitro and then used biopsies from 
human skin after discarded during panniculectomy surgery. In chapter 3, I discussed my 
results to understand the role IGF-1R in p53 target genes induction especially for pol eta 
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and p21. Also, I discussed potential future studies, in particular how we could apply these 
concepts derived from this work with human subjects. 
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Chapter 1: Introduction: 
    Human Skin:  
 Skin is the largest organ in the human body that accounts for almost 16% of the 
overall body weight and with a surface area between 1.5 to 2 m2. The skin thickness is 
different from one area to another, the thickness of eyelids is around 0.6 mm to around 
3.0 mm on the back, soles of feet and palms of hands (1). The skin covers the entire 
human body thus protecting from injury and loss of body fluids. Moreover, it is 
considered the first line of defense for the human body from various environmental 
factors. The skin prevents or reduces the admittance of foreign organisms such as 
microbes, viruses, and fungi, allergens and toxins. It protects our internal organs and 
tissues from sunlight and radiation exposure. Furthermore, there are other important skin 
functions such as temperature regulation, sensation, and production of vitamin D (2).  
   The skin of the human body consists of three layers which are epidermis, dermis, 
and hypodermis (Figure 1). All three layers of the skin work together to protect our 
internal organs from the external factors mentioned above. Each one of the skin layers 




Figure 1. Skin layers (3) 
The epidermis is the topmost layer of the human skin and it is the layer that is seen with 
the naked eye. The epidermis is comprised of 4-5 layers of cells depending on the area of 
the body (Figure 2) (4). Moreover, the epidermal layer consists of different types of cells 
including Merkel cells, Langerhans cells, melanocytes, and keratinocytes. The 
keratinocytes are the main cells types of the epidermis and it represents more than 90% of 
epidermal cells. The keratinocytes are produced from keratinocyte stem cells in the basal 
layer of the epidermis. During the division, some of these cells remain in the basal layer 
of epidermis and others move up to push up the old cells for forming the dead layer of the 
skin. During the transition from the basal layer to the surface of the epidermis, some 
changes occur in the cells (5). Moreover, keratinocytes have some function such as 
barrier from the sunlight and absorb the sunlight and convert it to vitamin D which is 
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beneficial for our skin, but a lot of sunlight exposure could be harmful because it may 
lead to formation some of the photoproducts in genomic materials of those cells (6). 
Those photoproducts cyclobutane pyrimidine dimers and pyrimidine (6-4) pyrimidine 
photoproducts in keratinocytes may cause some types of skin cancer because of those 
formations of photoproducts the sunlight is considered the major risk factor after aging 
for skin cancer. The sunlight exposure could cause some types of skin cancer such as 
squamous cell carcinoma (SCC) (Figure 3.A) and basal cell carcinoma (BCC) (Figure 
3.B). Squamous cell carcinoma originates in the mutated keratinocytes in type I and II of 
skin color. Basal cell carcinomas arise from the basal layer of the epidermis and this type 
of skin cancer is more common in areas of sun exposure (26). BCC and SCC are the most 






Figure 2. Epidermis layers and cells types (7) 
 
Figure 3 A, B. Non melanoma skin cancer. (A) Squamous cell carcinoma and (B) Basal 





Risk factors for skin cancer: 
Most skin cancers result from a combination of environmental and genetic risk 
factors. Ultraviolet radiation is the most significant environmental risk factor for causing 
skin cancer. On the other hand, genetic risk factors have a huge impact on causing skin 
cancer. Some individual characteristics raise the incidence of skin cancer such as skin 
color, family history, and genetic syndromes such as Xeroderma Pigmentosum (9). 
Moreover, advancing age is another important risk factor for the development of skin 
cancer. Previous studies have shown that geriatric people are more suitable for the 
development of skin cancer because of some changes that occur in their skin layers and 
chronic exposure to sunlight during their lifetime (10).    
 
Ultraviolet radiation: 
Although the skin protects us from UVR exposure by stimulating melanocytes to 
generate melanin that appears as tanned skin, the tanned skin is a sign of damage 
occurring at the skin, skin cells, and genomic material of our skin (DNA). Moreover, 
some types of UVR have the ability to penetrate the skin layers for causing photoproducts 
that may lead to potential tumor formation (9)(11). There is a strong correlation between 
UV and some types of skin cancer such as NMSC. Most of the skin cancer is related to 
more intense exposure to sunlight which is the major source for UVR in our Earth, with 
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more intensive exposure to sunlight leading to more sunburn occurrences that are a sign 
for cell death (9)(8). 
Ultraviolet radiation (UVR) is a kind of electromagnetic spectrum that is 
characterized by a short wavelength of more than 100 nm and less than 400 nm. UVR is 
separated into three different types which are UVA, UVB, and UVC, each type of those 
UVR penetrates different layers of skin because each one of these UVR has its own 
wavelength (9)(8)(12). The first type of UVR is UVA which is able to penetrate the 
dermis and leads to reactive oxygen species which affects indirectly DNA. Additionally, 
the range of its wavelength is from 315 to 400 nm and it represents between (90% to 
95%) of the sunlight in the earth (13). The second type of UVR is the UVB and it 
represents between (5% to 10%) of the sunlight that humans normally exposed on a 
sunny day. This type of UVR is able to penetrate the epidermis and is absorbed by DNA 
in keratinocytes via the formation of cyclobutene pyrimidine dimers (CPD) and 




Figure 4. Structures of the UV-induced DNA lesions (photoproducts from the sunlight in 
human skin) (14). 
The range of UVB reaches the earth is around 280nm to 315 nm. The last type of 
UVR is UVC which is content high energy with short lengths of the wave that is get 
absorbed by dead cells skin. The power of UVC is between 100 to 280 nm. UVR is the 




Figure 5. Penetration depth of various UV light into human skin.  
 
 
Table 1. Types of UVR, power of wavelength, the ability to penetration of skin layers, 




Patterns of exposure to UVR: 
 The patterns of UV exposure are associated with the development of various types 
of skin cancer. The workers who work outdoor for a long time during different seasons 
have been exposed to various intense sunlight (9). Also, people who work at outdoor 
occupations are exposed to sunlight chronically that leads to accumulation of 
photoproducts in their genomic materials, there is a correlation between chronic exposure 
to sunlight and different types of skin cancer especially BCC and SCC (15). On the other 
hand, melanoma skin cancer is associated with a history of sunburn and intermittent 
exposure to sunlight (16). Melanoma could develop through various ways such as 
workers at the intensive area of UV exposure at risk for developing melanoma skin 
cancer according to a pooled analysis of 15 combination studies (17). There is a 
limitation for studies of melanoma and outdoor occupation because of less evidence on 
other related factors such as protection materials, diet, and vacation.  
 
Advancing Age: 
Skin cancers are the most common cancers that occur in the United States. As 
evidenced around 3.5 million people are diagnosed with non-melanoma skin cancer each 
year in the United States (9)(18)(32). The first risk factor for the development of skin 
cancer is exposure to sunlight. Notably, advancing age is a second important risk factor 
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for the development of skin cancer, and a significant increase in skin cancer is noticed 
with increasing age. Most non-melanoma skin cancers occur in geriatric people as 
evidenced that around 80% of non-melanoma skin cancers occur in people over 60 years 
and 20% occur at younger people (19). However, the mechanisms by which advancing 
age increases the incidence of skin cancer are not well understood. The mechanism of 
aging leading to some morphological and physiological changes that occur in the human 
skin during age increasing, through reducing the thickness of epidermis and change in 
epidermal cells (13)(20). Also, reductions in the enzymatic activation of some protective 
cells such as melanocytes in geriatric people may contribute in the long term to decrease 
the ability of the epidermis to protect the genomic material (DNA) from wavelengths of 
sunlight (13). Growth factors play a significant role in how the cells in the skin respond 
to UV from the sun through the activation of different intercellular signaling pathways. 
One factor that is related to epidermis and epidermal responses is insulin-like growth 
factor-1. Insulin-like growth factor-1 is a hormone that has a similar chemical structure to 
insulin. This hormone is performing an important role in many growth and cellular 
responses. The gene that encodes the IGF-1 induction is the IGF-1 gene. IGF-1 consist of 
a single chain of the polypeptide which contains 70 amino acid linked by three disulfide 
bonds (21). In the skin, keratinocytes express the insulin-like growth factor-1 receptors 
however do not produce insulin-like growth factor 1 (IGF-1) (22)(23). Hence, 
keratinocytes depend on fibroblasts in the dermis layer of skin to produce the IGF-1. The 
activation of IGF-1R through IGF-1 involves various intercellular pathways such as 
11 
 
PI3k/AKT (24)(13). During the aging process, a large population of fibroblasts becomes 
senescent that leads to a decrease in the production of IGF-1 (19). This decrease in the 
production of IGF-1 in the skin leads to the lack of activation of IGF-1Rs in keratinocytes 
that could affect the cellular response of keratinocytes to exogenous stress, including to 
UV radiation (Figure 6) (19)(25). Moreover, these changes in keratinocyte responses 
could negatively impact other intercellular responses such as cell cycle arrest and 
apoptosis. Genetic factors also contribute to increasing the risk of skin cancer such as 










Xeroderma pigmentosum is a rare genetic disease that is associated with 
sensitivity for sunlight exposure. This disease is reported around the world and the 
incidence of this disease is around 1 per million people in the United States (26)(27). 
Xeroderma pigmentosum patient exposure to sunlight could lead to the development of 
skin cancer in this group of people because this group has a defect in the DNA repair 
mechanism (28). Moreover, xeroderma pigmentosum is classified into eight groups 
which are XPA, XPB, XPC, XPD, XPE, XPF, XPG, and XPV. This classification 
depends on multiple genes that have been involved in this disease (29). All XP groups 
have a similar clinical phenotype that includes a defect in the nucleotide excision repair 
except XPV which has the normal activation of nucleotide excision repair but it has a 
defect in the replication of UV photoproducts (Table 2) (28)(29). However, XPV patents 
have mutations in the POLH gene, which encodes the translesion synthesis protein 
polymerase eta (30). The mutation in XPV patients leads to a decrease in the ability of 
UV-exposed cells to replicate across the DNA photoproducts. This defect in the XPV 
gene increased the incidence of sunlight-induced skin cancer (31). People with XPV 
disease may have more survival rate compared to other groups of XP (27).  
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Table 2. The classification of XP groups and clinical phenotypes (27).   
 
Non-melanoma skin cancer: 
Non-melanoma skin cancer is the most common type of cancer in humans 
worldwide, which arises from keratinocytes in the epidermal layer of the human skin. 
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The annual estimated rate of incidence for non-melanoma skin cancer in the United 
States is around 5.4 million cases because some people have more than one (9)(32)(33). 
The rate of diagnosis of skin cancers is more than all of the other types of cancer 
combined, around 1 in each 5 Americans will be diagnosed with skin cancer at some time 
in their lifetime (33). The most common types of NMSCs are basal cell carcinoma and 
squamous cell carcinoma, and BCC is more common than SCC (33)(34)(35). The most 
common human skin site for development NMSC is the head and neck region because it 
frequently gets exposed to sunlight (36). The most significant and dominant risk factor 
for development NMSC is exposure to ultraviolet wavelengths that come from the 
sunlight (35). That frequent exposure to sunlight is stimulating for the formation of UV 
photoproducts in DNA of the keratinocytes. If the cells are not able to properly repair 
those photoproducts. Those photoproducts may lead to mutations in DNA and that leads 
to starting NMSC in epidermal keratinocytes (9). There is a correlation between aging 
and skin cancer due to lifetime exposure to UVR from the sunlight. The lifetime of 
exposure to UVR is starting during childhood until the later time of our life which means 
we accumulate the mutation of sunlight exposure with time which results in 
tumorigenesis (9)(35). In fact, 80% of NMSC occurs in people over 60 years old that is 
related to the accumulation of mutation in their skin cells and also to a physiological 
change in geriatric people with the aging process (19). The NMSC has less rate of death 
compared to other types of cancer, but it has a high cost of treatment (35). 
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DNA Translesion Synthesis Polymerases:  
Translesion synthesis is a conserved mechanism that allows DNA replication 
polymerases to bypass past lesions in DNA such as CPDs and fill it with the correct DNA 
nucleotide bases to avoid any stalling in replication mechanisms (37)(38)(39)(40). This 
mechanism occurs by changing the DNA polymerase to a specialized translesion 
synthesis polymerase which has an active site that is able to simplify the process of 
fulling DNA with opposite nucleotides basses to damaging nucleotides (37)(38)(40)(41). 
However, when this polymerase copies undamaged DNA strands, it may lead to an 
increase in the risk of mutagenesis because of its low fidelity. The major DNA 
polymerase that is responsible for translesion synthesis polymerase within replications of 
DNA belongs to Y-family such as pol eta and along with B-family (9)(40)(41). While the 
TLS has a significant role in originating mutations, TLS polymerases have their own 
features that assist them predominantly to remove right code from DNA damaging 
strands. To limit the risk of getting unwanted mutations from those polymerases, they are 








Bypassing the photoproducts in DNA damage is an important pathway of cellular 
response that is taking place during the replication processes. DNA polymerase eta is a 
member of the Y family DNA polymerase which is encoded by the POLH gene (XPV 
gene) in human and RAD30 gene in S. cerevisiae (38)(41)(42). This gene is mutated in 
xeroderma pigmentosum variant (XP-V) patients. DNA polymerase eta is characterized 
by a high level of fidelity of replicating photoproducts in DNA that occur by sunlight and 
it is characterized an error-free during bypass of photoproducts occurring during the 
DNA replication process (38)(39)(40)(43). The reason that DNA polymerase eta is an 
accurate polymerase across the photoproducts is that it is able to fill the new strand of 
DNA with the correct complementary nucleotides opposite the damaged nucleotides in 
the parental DNA strands. Thus, this DNA polymerase helps to avoid any stalling of 
replication forks during DNA replication, which protects cells from undergoing apoptosis 
(40)(44). While in the absence of polymerase eta, alternative, low fidelity and error-prone 
DNA polymerases replicate UV lesions, which may lead to more UV mutations in DNA 
because other DNA polymerases may involve (Figure 7) (37)(45)(46).  
In previous studies, polymerase eta was shown to have a significant role in how 
cells respond to exogenous stress, including UV. The great study which published in 
2017 and studied the role of pol eta in different cells line, using primary wild type 
fibroblasts from control patients with no XPV, human diploid primary XPC fibroblast, 
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and XPV primary fibroblast from skin biopsy of Brazilian patients with XPV disorder 
(40). This paper gives us an idea about the mechanisms of pol eta with exogenous stress 
exposure, the fibroblasts with the mutated POLH gene did not protect the cells’ survival 
after a single or double dose of UV exposure. On the other hand, the primary fibroblast 
with XPC and wild type (no POLH gene mutation) showed a significant increase in cell 
survival with double UV exposure. This increase in cell survival with non-POLH mutated 







Figure 7. The mechanisms of polymerase eta to replicate UV photoproducts.  
 The study in 1999 was testing the capacity of different translesion synthesis 
polymerase for bypassing CPDs, using a free cell assay for isolated DNA polymerases by 
using HeLa cells. This study showed that the polymerase eta is able to bypass the CPDs 
and continue replicating the DNA strands (30). On the other hand, another polymerase 
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such as polymerase α was not able to bypass the UV photoproducts (CPDs), it got stuck 
in the CPDs lesion. This study proves the capability of the polymerase eta to bypass the 
CPDs and also the polymerase is the XPV gene product (30).  
 
Tumor Suppression Protein p53: 
The p53 is a tumor suppression protein and a transcription factor (47)(48). It plays 
an important role in controlling hundreds of genes, and most of those p53 target genes are 
involved in different cell mechanisms such as cell growth and cell division. In the normal 
condition, p53 has a short half-life that is regulated by his stability, but under abnormal 
condition or cellular stress response, the p53 cellular level is increased by inhibiting p53 
degradation (47)(48). Moreover, p53 is called the guardian of the genome that is related 
to p53 significant role in cancer as a tumor suppression protein and is encoded by the 
TP53 gene (48)(49). p53 upregulates other different cellular mechanisms such as DNA 
repair, cellular senescence, and apoptosis and it also take a place for stimulating different 
mechanisms in various organs, including skin, immune system, and generation blood 




Figure 8. Different stress activate induced p53 induction or activate p53 (48).  
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Moreover, some of the p53 target genes play a critical role in aging and cancer. 
According to published data, p53 inhibits the cell proliferation and eliminates cancer 
cells. Mouse studies show that mice with mutated p53 are more susceptible for 
developing cancer, and thus removing p53 gene for any reason in mice models lead to 
increased cancer development and death (52)(53)(54). Mutation in the TP53 gene may 
alter the normal cellular response during the stress. As a result of TP53 mutation, this 
could be the main reason for the development of different types of cancers (55). There are 
many papers have been studying the p53 target genes. Mutations in p53 gene leads to 
abnormal function of the wild type proteins and may also activate new functions for those 
proteins in cancer predispositions (55).  
The p53 protein plays a significant role in cell cycle arrest and apoptosis to inhibit 
tumor cell development. The mechanism of cell cycle arrest to repair any lesions in the 
cellular genome is dependent on the activation of p53 that is primarily mediated by the 
p21 protein. This activation of the p21 gene by p53 occurs by p53 binding to two sites in 
the p21 promoter. Hence, the cellular level of p21 is increased by p53 activation. The p21 
protein is the first p53 target gene which was isolated by using the subtractive 
hybridization method (52)(56)(57). The p21 protein is a cyclin-dependent kinase (Cdk) 
inhibitor that is regulated by p53 and a member of the CDK family. The induction of p21 
depends on the activation of p53. When p21 gets activated, the cells arrest in the G1 
phase, giving cells time to repair the damage in DNA. This arresting of cells will help 
cells to maintain genomic stability and fix the mutation which could lead to abnormal 
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growth of the cells (52)(56)(58). The cells moving through the cell cycle is regulated by 
checkpoints. For instance, if after the cell’s are exposed to UVB resulting in the 
formation of photoproducts in the cell’s DNA, the cell will arrest in the G1 phase and 
induce the expression of the genes that help or are able to fix the DNA damage. The 
benefit of arresting the cells in G1 is for preventing the replication of damaged DNA that 
will lead to defective in chromosomes (52)(59). Nowadays, there is a lot of debate about 
the p53 and p21 that is related to their functions in cell cycle arrest and apoptosis.   
The extraordinary study was done in late 1993, this work was testing if the 
induction of p21 depends on p53 activation. This study showed that the p53 induced and 
regulated the induction of p21 in a dependent manner, the induction of p21 was seen in 
the mouse, rat, and human (56). Moreover, a study in 1995 was done to study the 
regulation of p21 in the normal and neoplastic tissues. Based on this study, p53 plays a 
significant role in the induction of the p21 for the regulation of the cell cycle arrest, the 
found that the p53 regulate the p21 through the p53 binding site (60). Those two papers 
did a great work to study the role of p53 in activation of p21 in a dependent manner.  
 Some studies show that p53 plays an important role in cellular response for UV 
induced DNA damage. The p53 gets activated for DNA damaging response and also it 
stimulated different of its target genes which are involved in the repair of DNA damage. 
Moreover, p53 activates different DNA polymerase for accurate replication of DNA 
damage, including the polymerase eta which is a type of DNA polymerase that is able to 
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accurate replication of UV photoproducts in cells genomic (51). There are some studies 
show that p53 regulates the induction of polymerase eta in different cells.  
 One study in 2006 tested the role of p53 in the induction of polymerase eta in 
different cell types. This study used normal fibroblast cells and XPV fibroblast cells 
derived from XPV patients, this article demonstrated that p53 regulates the induction of 
polymerase eta in both p53 dependent and independent manner. Overexpression of p53 
during exogenous stress such as UV stimulates the polymerase eta to bypass the UV 
photoproducts to continue replication of DNA new strands (28). Another paper was 
published in 2016, this paper used primary fibroblast with no mutation, primary XPC 
fibroblast, and primary fibroblast with XPV mutation. It showed that with p53 inhibitor 
the induction of polymerase eta was decreased, this reduced induction of polymerase eta 
was due to inhibition of p53 activation (40).  
 
Previous studies on IGF-1 in vitro, ex vivo, and in vivo:  
 Insulin-like growth factor-1 has a critical role in how epidermal keratinocytes 
respond to UV and plays a significant role in the development the non-melanoma skin 
cancer in geriatric people. Therefore, before examining why the non-melanoma skin 
cancer in geriatric people has a high incidence, it is necessary to understand and discuss 
some of the previous studies in IGF-1 in older people. Nonetheless, one relevant study 
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used the primary keratinocytes and fibroblasts to test the activation status of IGF-1R in 
keratinocytes. This study cultured keratinocytes without adding IGF-1 to the growth 
media and then exposed the keratinocytes to UV to form photoproducts in the cells’ DNA 
(61). They showed that when keratinocytes were exposed to UV irradiation, the cells with 
inactive IGF-1Rs did not undergo senescence but instead continued proliferating with 
DNA damage. Keratinocytes proliferating with DNA damage may have a potential risk to 
develop carcinogenic mutations. Interestingly, this study provides evidence for the role of 
IGF-1R in inhibiting the UV induced carcinogenesis as well as the roles of dermal 
fibroblasts which is maintaining appropriate activation of IGF-1R in keratinocytes and 
how the reduction of IGF-1 in geriatric people could lead to the development of the aging 
related non-melanoma skin cancer (61). Additionally, one interesting study is about the 
exogenous growth factors and survival of keratinocytes after exposure to UVB. The 
keratinocytes need a specific growth factor for activation IGF-1R to maintain the survival 
and well responses to UVB induced DNA damage. The IGF-1R mediated the survival of 
keratinocytes by two pathways which are PI3 and MAP kinases (62). As a result, the 
exogenous IGF-1 could be a new way for the treatment of non-melanoma skin cancer 
according to his significant protective effect in survival of keratinocytes and activation of 
cellular response to UV induced DNA damage in keratinocytes.  
Moreover, there is a study of the IGF-1 role in cell cycle arrest and the repair of CPDs, 
focusing on the rate of CPD removal when the keratinocytes are treated with IGF-1. The 
data of this paper show that the keratinocytes treated with IGF-1 are capable of removing 
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the CPDs at a faster rate than in the absence of IGF-1. Also, IGF-1 activation arrests the 
cells in G1 phase to give some time to repair and avoid any potential of carcinogenesis in 
those cells, leading to increased survival of keratinocytes (63). Furthermore, this role of 
IGF-1 in the epidermal layer of the skin supports the link between the IGF-1 and 
epidermal photoresponse that is through decreasing in the expression of IGF-1 leads to 
inactivation of DNA repair pathways and passing the cells with lesions through cell cycle 
with potential carcinogenesis formation (63). Some previous studies have shown that 
when the number of senescent fibroblasts is decreased, the expression of IGF-1 increases. 
In fractional laser resurfacing study, geriatric people treated with FLR on their sun-
protected or sun-exposed skin. Three months later the punch biopsies were taken from the 
skin that treated with FLR and untreated skin. The QRT-PCR was then preforming to 
determine the level of IGF-1 (19). The expression of IGF-1 increased in treated and 
untreated skin in geriatric people after treated with FLR. Also, the population of 
senescent fibroblasts is decreased compared to before treated with FLR (19). Based on 
this study, the FLR decreased senescent fibroblasts and improved the expression of IGF-
1, which may lead to correct cellular response of keratinocytes to UVB induced DNA 
damage. FLR has a significant effect in reducing aging associated with NMSC in 
geriatric people. In a microneedling device study in geriatric people, it was shown that 
microneedling upregulated the expression of IGF-1 in geriatric people and reduced the 
proliferation of keratinocytes with unrepaired DNA damage. Thus, the microneedling 
device may have the ability to protect the geriatric people from UVB damaged 
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proliferation in keratinocytes that could lead to reducing the aging associated with NMSC 
(64). In summary, multiple studies have implicated that low IGF-1 expression levels in 
geriatric people plays a significant role in IGF-1 in cellular response in keratinocytes.  
 Because of the importance of avoiding the stalling of replication forks in DNA 
damage, the cells use different DNA mechanisms to avoid the stalling in the replication 
of DNA damage such as the translesion synthesis DNA polymerase to bypass the DNA 
lesions. In humans, mutated POLH is not able to bypass the photoproducts, which may 
lead to stalled replication forks. Moreover, two interesting papers tested the induction of 
polymerase eta in XPV cells derived from people who have the XPV. That was done to 
see the expression of polymerase eta after UV exposure and the consequences of this 
mutation. The data have shown that XPV cells are not able to bypass the UV 
photoproducts, which may lead to forks stalling and apoptosis (40)(28).  
 Based on previous articles, I propose to investigate the function of IGF-1 in 
geriatric and younger people and its effect on the activation of polymerase eta and p21. 
This proposal is based on the different expression levels of IGF-1 observed in the old and 
young people after switching the dermal fibroblasts to the senescent stage in the cellular 
response of keratinocytes to UV. For example, what will happen to p53 target genes such 
as polymerase eta and p21 in keratinocytes in the absence of IGF-1 and after exposure to 
UV? If inappropriate induction of IGF-1 reduces the activation of polymerase eta and 
p21, more cells will go through the cells cycle with unrepaid DNA damage, leading to 
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cancer growth in epidermis layer of the skin, which supports the aging associated with 
NMSC.  
 
DNA damage and repair:  
 During our lives we are exposed to DNA damaging agents continuously and these 
agents may have a negative impact on our health and lead to the development of some 
types of diseases. These DNA damaging agents are from our environment or from within 
our body. The most endogenous DNA damage comes from the chemical reaction of DNA 
involves in different metabolic reactions such as hydrolytic and oxidative reactions. 
Those damages could lead to inherited diseases and cancer (65)(66). On the other hand, 
there are a lot of exogenous agents that damage the DNA such as sunlight, ionizing 
radiation, diet, and lifestyle. Therefore, our cells have to respond to these damages to 
activate different mechanisms of DNA damaging response for repairing those alterations 
and to protect themselves from apoptosis or transform to cancer cells. The varieties of 
DNA repair mechanisms have been activation depend on the type of genotoxic agent and 
type of damage to accurately repair the DNA damage and to avoid any potential risk for 






UVB-irradiated keratinocytes with deficient IGF-1 signaling will be unable to properly 
induce the expression of p53 target genes that protect against the mutagenic effects of 
UVB radiation.  
Specific aims: 
• Aim 1: Examine how the loss of IGF-1 signaling impacts the induction of 
polymerase eta in UVB-irradiated human skin keratinocytes in vitro. 
• Aim 2: Determine how the loss of IGF-1 signaling in human skin ex vivo affects 
the UVB-dependent induction of polymerase eta and p21. 
• Aim 3: Examine the UVB-dependent induction pol eta and p21 induction in 









Chapter 2: Material and methods 
  
Introduction:  
This chapter will discuss the model systems, procedures, and analysis that I have 
been used to answer my experimental questions in this thesis. Two models that I used: in 
vitro telomerase-immortalized normal human foreskin keratinocytes (N-TERTs) cells and 
ex vivo human skin.  
 
Cell culture: 
Telomerase-immortalized normal human foreskin keratinocytes (N-TERTs) were 
cultured in EpiLife medium containing human keratinocyte growth factors supplement 
(Thermo Fisher Scientific) and 5 ml of 100X Pen/Strep (penicillin/streptomycin) that is 
described as medium with IGF-1 (+IGF-1). N-TERTs are also cultured in EpiLife 
medium containing human keratinocyte growth factors except IGF-1, or -IGF-1 medium. 
All experiments were done when the cells reached 90% confluence, and low passage 
numbers were used because more than 30 passage is not recommended. The cells were 
grown for 3 days with normal growth factor and then the medium was changed to 
medium with or without IGF-1 incubate for 24 hours. After that, the cells in plates were 
exposed to Philips F20T12 broadband UVB bulb. Cells were treated with DMSO, 10 mM 
AG538 (IGF-1R inhibitor), 20 mM α-pifithrin (p53 inhibitor) for 30 mins prior to 
30 
 
exposure to a Philips F20T12 broadband UVB bulb and were then incubated for 24 
hours. All cells were grown in a 5% CO2 humidified incubator at 37




 For passaging N-TERT, the medium in the plate was removed and the plate 
washed with 1X PBS followed by adding 3 ml of 0.05% Trypsin-EDTA 1X to the N-
TERT with 10-15 minutes incubation at 370C. After the cells come off the plate, the 5ml 
of DEME medium (content 10% of FBS, 5 ml of 100X penicillin/streptomycin, and 5 ml 
of 100X glutamine) was added to inactivate the trypsin, then transferred to a 15 ml tube 
for centrifuge at 2000 rpm for 5 mins. The supernatant was discarded and 2 ml of 1X 
PBS was added to wash the pellet (do not disrupt the pellet). The pellet was resuspended 
with 5 ml of EpiLife medium by using a 5 ml pipette. The resuspended cells were added 
to a 10 cm plate with fresh EpiLife medium.       
 
Cells count: 
 Cells count assay was done for culture a specific number of cells for doing some 
of the survival assays. The cells pellet was resuspended in 5 mL of EpiLife medium, 
mixed well, and then 10 ul of resuspended cells were mixed with 10 ul of trypan blue 
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stain in a 1.5 microfuge tube. Ten ul of the resuspended cells mixed with trypan blue 
stain was placed on the specific glass slide to inserted in the cell counted instrument. The 
cell count was determined by using the Countess II FL instrument.    
 
UVB Irradiation: 
Irradiation of the N-TERT with UVB was done by using Philips F20T12 
broadband UVB bulb. The UVB turned on before exposure the cells to UVB to warm up 
UVB bulb, and the plates were placed in the central of UVB light to get the same fluence 
of UVB light. The intensity of UVB light was measure continuously and the bulb was 
checked before doing the experiments. The cells were irradiated with different doses of 
UVB (0, 25, 50, 100, 150 J/m2) at a dose rate of 5 J/m2/sec (0, 5, 10, 20, 30 seconds) in 
EpiLife medium and cells were returned to the same incubation for 24 hours. In some 
experiments, the cells were irradiated with multiple doses of UVB.  
 
Bio-Rad Protein Quantification Assay Protocol: 
 Frozen cells or tissue lysates were heated in the microtube warm up for few 
seconds and then placed on ice. The BSA standard was prepared by using homemade 
solution or purchased, 800 ul of PBS was added to 6 tubes and then BSA standard 2 
mg/ml was added 0, 1, 2, 3, 4, 5, ul to each of the tubes (for the final concentration 0, 2, 
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4, 6, 8, 10 ug/ml of BSA) adding 200 ul of Bradford reagent was the last step for making 
the standard. After that, sample lysates were prepared by adding 795 ul of PBS to each 
tube with 5 ul of each lysate and was followed by the addition of 200 ul of Bradford 
reagent. Samples were vortexed well and then pipetted in duplicate or triplicate into 96-
microplate along with the BSA standard. The absorbance at 595 nm was measured with a 
plate reader (Bio-Tek).  
 
Immunoblotting:  
 EpiLife medium was removed from the plates and then cold PBS was added to the 
plates. After that, the cells were scraped off and transferred to microcentrifuge tubes. 
Cells were then centrifuged for 2 mins at 6000 rpm, and the supernatant was removed. 
The pellets were and lysed with RIPA lysis buffer containing 1 mM DTT, 0.1 mM 
PMSF, 10 mM NaF, 1 mM Na2VO3, 1/200
th Protease Inhibitor Cocktail (Sigma P8340), 
and 10 mM B-glycerophosphate, and then centrifuged in a microcentrifuge at maximum 
speed for 15 mins. After centrifugation, the supernatant was transferred to new 
microcentrifuge tubes. Chromatin-associated proteins were obtained from the cells by 
three extractions with a cytoskeletal lysis buffer (10 mM Tris-HCI pH7.4, 100 mM NaCl, 
300 mM Sucrose, 3 mM MgCl2, 1 mM EDTA, 1 mM NaVO3, 10 mM NaF, and 0.1% 
Triton X-100). Cell soluble and chromatin lysates were separated on an SDS-PAGE and 
then transferred the nitrocellulose membrane by semidry electrophoresis. Then, the 
33 
 
membrane was stained with 0.5% Ponceau S stain for 1-2 min to visualize the total 
protein levels. After staining, the membrane was incubated in 5% of dry milk in TBST 
(Tris-buffered saline containing 0.1% Tween-20) from 10 to 30 mins at room temperature 
on the shaker. The membrane was incubated with the diluted antibodies in TBST 1:2000 
overnight at 40C against polymerase eta (Santa Cruz Biotechnology B-7), p21 (Santa 
Cruz Biotechnology F-5), p53 (Cell Signaling S15), Actin (Bethyl A300-485A), PCNA-
ub (Cell Signaling D5C7P), Total PCNA (Santa Cruz Biotechnology PC10), RPA (Santa 
Cruz Biotechnology H-7), phospho-Chk1 (Cell Signaling S345), total Chk (Santa Cruz 
Biotechnology G-4), phospho-Chk2 (Cell Signaling T68),  XPC ( Santa Crus 
Biotechnology D-10), and DDB2 (Cell Signaling D4C4) (Table 2). After the membrane 
was incubated with the primary antibodies, the membrane was washed four times with 
1X TBST for 5 mins for each wash. The membrane was next incubated with the 
secondary antibody (anti mouse, anti-rabbit, and anti-goat) diluted in 5% dry milk plus 
TBST for 1 hour at room temperature and then washed five times with 1X TBST for 5 
mins for each wash. Finally, the specific bands were visualized by chemiluminescence 
with either Clarity ECL substrate (BIO-RAD) or Supersignal West Femto substrate 
(Thermo Scientific). The Molecular Imager Chemi-Doc XRS+ imaging system was used 
to visualize the bands (Proteome Analysis Laboratory in the Pharmacology and 
Toxicology Department at Wright State University) and Image Lab (Bio-Rad) was used 




Table 3. Primary and secondary antibodies used. 
 
RNA purification and RT-qPCR: 
 Cell pellets were placed on ice while adding 1 ml of Qiazol (or TriZol) and were 
then homogenized by pipetting several times or vortexed for 10 seconds. Tubes were 
incubated for 5 mins at room temperature for complete dissociation of nucleoprotein. 
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Two hundred ul of chloroform was added (1/5 volume of TriZol) and then the tubes were 
mixed up and down by hands for 15 seconds and incubated for 2-3 mins at room 
temperature. Centrifugation was done at maximum speed for 15 mins in a cold 
centrifuge. The top layer was transferred to new microfuge tubes and 400 ul (equal 
volume) of 70% RNase-free ethanol was added to the tube, which was then vortexed. 
Then, all samples were loaded into the RNeasy column and spun at maximum speed for 
20 seconds, discard flow-through. The RNeasy columns were washed with 700 ul of 
RW1 and spun again for 20 seconds at maximum speed, discarded flow-through and 
washed with 500 ul of RPE, and then spun for 20 seconds at maximum speed, discarded 
flow-through and washed again with 500 ul of RPE and spun at 10,000 rpm for 2 mins. 
The columns were transferred to new collection tubes, spun at maximum for 1 min. The 
columns were transferred to 1,5 ml microfuge tubes and added 50 ul of RNase-free water 
to the columns, incubated for 3-4 mins, then spun at 10,000 rpm for 1 min to elute the 
DNA and discarded the columns. Samples were stored at -200C. The concentration of the 
RNA was determined by using a Nanodrop Spectrophotometer. Moreover, for doing the 
reverse transcription was used the Qiagen's QuantiTect Reverse Transcription Kit 
(Qiagen 205311), then samples with the lowest amount of RNA concentration were 
calculated to have the same of RNA in the high samples (to determined how much RNA 
in the 12 ul), sterile water was used to bring volume up to 12 ul, RNA samples were 
prepared in small PCR tubes. Then 2 ul of 7X genomic DNA wipe-out buffer was added 
to each sample and the thermal cycle was used to incubated samples at 420C for 5 mins. 
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After that, master mix of the reverse transcription was prepared for adding 6 ul of master 
mix to each sample (RT buffer, primer, and RT enzyme ThermoFisher 4352042) ( for 
each reaction, 4 ul of RT buffer, 1 ul of primer, and 1 ul of RT enzyme), thermal cycle 
was used to incubated samples at 420C for 15 mins and then at 950C for 5 mins. The 
mRNA levels of polymerase eta and p21 were measured on a Bio-Rad CFX96 system by 
using Taqman qRT-PCR primer-probe sets and were normalized to B2M. 
 
Cell survival:  
 MTT Assay: 
 Cells were grown in EpiLife medium, exposed to a single or multiple dose of 100 
J/m2 of UVB and incubated for 24 or more hours. The EpiLife medium was removed, 2 
ml of MTT reagent with medium was added and incubated for 45 mins at 370C (1.25 ml 
of 5 mg/ml of MTT reagent to 23.75 ml of EpiLife medium for a final concentration 0.25 
mg/ml of MTT reagent), the MTT reagent was removed after the incubation time. Then 1 
ml of DMSO was added to each plate to solubilize the MTT dye, the plates were placed 
on the shaker to complete solubilization. The 100 ul of the solubilized dye was 
transferred to 96 well plates by pipette in duplicate or triplicate to take the average. The 




Clonogenic survival assay: 
  Cells were grown as with the MTT assay after that 200 cells were cultured in 10 
cm plate with or without growth factors (IGF-1), EpiLife medium was used to culture the 
N-TERTs. The cells were incubated at 370C for 10-14 days, then the medium was 
replaced every 6 or 7 days (cells were taken 6-7 days to form visible colonies). Cells 
were stained with crystal violet (removed medium, wash with PBS, fixed in cold 
methanol for 20 mins in the freezer, and stained with crystal violet). Cells colonies were 
counted in each plate (if unsure colony see it under the microscope).  
 
HPRT mutagenesis assay: 
 Cells were plated into two 10cm plates and when the two plates reached 30% 
confluency, the medium was changed to medium containing or lacking IGF-1. Then, the 
plates were exposed to the first dose of 100 J/m2 UVB. Twenty-four hours later the two 
plates were exposed to a second dose of UVB (100 J/m2) or not, incubated for 24 hours 
and then the medium was replaced with growth factors (including IGF-1). After the 
medium was replaced with IGF-1, the plates were incubated for three days. The plates 
were then trypsinized with 0.05% Trypsin-EDTA 1X and resuspended in 5 mL of EpiLife 
medium with IGF-1. A cell count was performed to determine the cell concentration. 
Next, 100 cells were plated into two 10cm plates for determining the plating efficiency 
(PE) after 10-14 days. In addition, 200,000 cells were plated into twenty 10 cm plates that 
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were then treated with 6-thioguanine (4 ug/ml) for 14 days to select cells with mutations 
at the HPRT locus. After 5 or 7 days the medium was replaced on all plates with fresh 
medium (-/+ 6-thioguanine). Colonies were counted after staining with crystal violet.  
 
Crystal violet staining: 
 The cells were treated and incubated for 10 to 14 days to form colonies. The 
medium was removed from the plates and washed two times with 1X PBS. Then, 1 ml of 
ice-cold 100% methanol was added to each plate, which were then placed at -20 for 20 
minutes to fix the cells. After removing the methanol, 2 ml of crystal violet (0.5% crystal 
violet in 25% methanol) was added to each plate to stain the colonies for 10 minutes at 
room temperature on a shaking platform. The stain was removed and excess stain was 
removed by running distilled water over the plates. The plates were placed upside down 
on the bench overnight to let the plates dry. The colonies were then counted to determine 









 The cells were treated as same as I describe previously, after incubation time the 
cells were trypsinized with 0.05% Trypsin-EDTA 1X. The cells were centrifuged at 1500 
rpm for 5 minutes at room temperature. Then, the medium was removed, and the cells 
were resuspended in 1 ml of PBS and mixed well. Cells were then centrifuged at 4000 
rpm for 5 minutes at room temperature. The pellet was vortexed with 1 ml of ice-cold 
70% ethanol for a minute. After fixation, the cells were pelleted by centrifugation and 
ice-cold 70% ethanol was removed. The cells were washed again with 1 ml of PBS and 
centrifuged again at 4000 rpm for 5 minutes at room temperature. During the 
centrifugation, the propidium iodide (PI) staining solution was prepared (1 ul of 10 
mg/ml RNase A and 5 ul of 10 mg/ml propidium iodide per ml of solution). The 
supernatant was poured off and the pellet was resuspended with 1 ml of PI staining 
solution. Cells were then analyzed on the flow cytometer.   
 
Work with human skin: 
 De-identified human skin discarded during the abdominoplasty surgery was cut 
into small pieces and were then treated topically with DMSO or 20 μM AG538. 
Alternatively, the skin was injected the PBS or IGF-1 (1 ml of 500 ng/ml) just below the 
epidermis. After incubation of the skin for 30 mins in a 370C water bath, the skin was 
exposed or not to UVB (800 J/m2) and then incubated for an additional 24 hours. A heat 
40 
 
shock procedure was then done (incubation in hot 600C water for 15-20 seconds and then 
cold ice water for 10-15 seconds) to loosen the epidermis from the dermis. The epidermis 
was removed with curette, transferred to new microfuge tubes containing 500 μl of 
Qiazol (or TriZol). The punch biopsies were disrupted by using a BioMasher II pestle and 
a pellet pestle Motor. The RNA was purified from the epidermis as described above. Q-
PCRs were done to measure target gene expression levels. Furthermore, western blotting 
was done by incubating the epidermal tissue in tubes containing 200 μl of RIPA buffer on 
ice. Epidermal tissues were sonicated on ice (10-15 brief pulses for three times and two 
times counted to 10 seconds) to break and lyse the tissue. The sonicated tissue was 
incubated on ice for 15 mins and then centrifuged in a cold centrifuge for 20 mins at 
maximum speed. Supernatants were transferred to new microfuge tubes and Bio-Rad 
protein assays were done to determine the protein concentration to load the same amount 
of protein on SDS gels. 
 
 





Chapter 3:  Results and Discussion: 
Introduction: 
 In this chapter, I will present my results related to my experimental questions. I 
will discuss my result for cells in vitro and for human skin ex vivo. Also, I will discuss 
some future plans to continue this work.    
 
The effect of IGF-1 loss on the UVB-dependent induction of p53 targets genes (pol 
eta and p21) in the telomerase-immortalized normal human foreskin keratinocytes 
(N-TERTs) cells in vitro 
 The tumor suppression protein p53 is known to regulate the expression of many 
genes which have been involved in the cellular response to DNA damage caused by 
exposure to UVB light, including genes involved in DNA repair, cell cycle arrest, and 
translesion synthesis (Figure 10A). Because previous studies have shown that IGF-1 
impacts how keratinocytes respond to UVB radiation (62)(63) and that NMSC-prone 
geriatric skin is deficient in IGF-1 (19)(64), I decided to examine how IGF-1 signaling 
impacts p53 target gene expression in UVB-irradiated N-TERT keratinocytes in vitro.  
To determine whether IGF-1 impacts the activation of p53 target genes, N-TERTs 
keratinocytes were incubated for 24 hours in the absence or presence of IGF-1 in the cell 
culture medium and were then exposed to 100 J/m2 of UVB. Twenty-four hours after 
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UVB exposure, the cells were harvested and cell lysates were prepared for western blot 
analysis of p53 target genes. In control cells containing IGF-1 in the culture medium, the 
protein levels of the p53 regulation targets p21, pol eta, DDB, and XPC were all 
increased. However, higher inductions (approximately 3-fold) were seen for p21 and pol 
eta, but only modest increases were observed for DDB2 and XPC. On the other hand, in 
cell lacking IGF-1 in the culture medium, induction of the p53 targets was not observed 
(Figure 10B, C).  
To confirm these results at the mRNA level, Q-PCR was carried out using RNA 
purified from the cells as described above. However, as mRNA levels are expected to 
peak at an earlier time point then protein levels, cells were harvested 12 hours after UVB 
exposure. The results showed that though p21 and pol eta mRNA levels increase by 4-5 
fold in control cells exposed to UVB (Figure 10D), the mRNA levels only increased by 







































































































































































Figure 9. The withdrawal of IGF-1 abrogates the UVB-dependent induction of the 
p53 targets p21 and pol eta in human keratinocytes in vitro. (A) Schematic showing 






























































in response to UVB radiation. (B) N-TERT keratinocytes grown for 24 hr in the absence 
or presence of IGF-1 (10 ng/ml) and were then exposed to 100 J/m2 of UVB radiation. 
Cell lysates were prepared 24 hr later and were analyzed by western blotting with 
antibodies against pol eta, p21, XPC, DDB2, and actin. (C) The graphs represent 
quantitation (average and SEM) of three or more independent experiments performed as 
in (B). (D) N-TERT keratinocytes grown for 24 hr in the absence or presence of IGF-1 
(10 ng/ml) and were then exposed to 100 J/m2 of UVB radiation. Cell lysates were 
prepared 12 hr later and were analyzed by Q-PCR pol eta and p21.   
 
 
Induction of p53 target genes by UVB radiation only occurs in cells with wild type 
p53 
 To confirm that induction of p21 and pol eta by UVB exposure is p53-dependent, 
the expression of these proteins was next examined in other cell lines with normal, wild-
type p53 and in HaCaT cells, which are a keratinocyte cell line with mutant p53. In 
addition to using N-TERT keratinocytes as a cell line with wild-type p53, U2OS (human 
bone osteosarcoma epithelial cells) and NHF1 (foreskin fibroblasts) cells were also tested 
for UVB-dependent gene induction. All cells were grown and were then exposed to 100 
J/m2 of UVB and harvested western blot analysis. An induction of the p53 targets genes 
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p21 and pol eta were increased in all of the cell lines except HaCaT cells (Figure 11A). 
This result confirms that p21 and pol eta UVB dependent are p53-dependent because the 
HaCaT cells have a mutation on the p53 gene are not able to express p53 targets genes 
p21 and pol eta. Otherwise, the cells that do not have a mutation on p53 were able to 
produce p21 and pol eta after exposure to UVB radiation.  
Moreover, to confirm the significant role of p53 in the induction of p21 and pol 
eta, the p53 inhibitor pifithrin-α was used in N-TERTs. As shown in (Figure 11B, C), 
pifithrin-α treatment significantly reduced the expression of p21 and pol eta. 
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Figure 10. The UVB-dependent induction of pol eta and p21 is p53-dependent in 
human cells. (A) N-TERT keratinocytes, U2OS osteosarcoma cells, HaCaT 
keratinocytes, and NHF1 fibroblasts were exposed to 100 J/m2 of UVB radiation and then 
incubated for 24 hr. Cell lysates were prepared and analyzed by western blotting with 
antibodies against the p53 target gene products pol eta and p21. Among the indicated cell 
lines, the HaCaT keratinocytes have two mutant p53 alleles. (B) N-TERT keratinocytes 
were treated with vehicle DMSO or pifithrin-α for 30 min before exposure to UVB 
radiation. Cells were harvested 24 hr later and analyzed by western blotting with 
antibodies against pol eta, p21, and actin. (C) The graphs represent quantitation (average 































These results demonstrate that the induction of p21 and pol eta in response to 
UVB radiation in N-TERT keratinocytes is dependent on p53 function. 
 
Characterization of the UVB dose- and time-dependent induction of p21 and pol eta 
in UVB-irradiated N-TERTs as a function of IGF-1 status 
 To further confirm the role of IGF-1 in the UVB-dependent induction of pol eta 
and p21, N-TERTs were grown in EpiLife medium with or without IGF-1 prior to 
exposure to different doses of UVB (0, 25, 50, 100, 150 J/m2 dose of UVB). Though both 
p21 and pol eta protein levels were found to be increased by UVB exposure in a dose-
dependent manner in control cells with medium containing IGF-1 (Figure 12A, B), much 
less induction of these proteins was observed in cells lacking IGF-1 in the culture 
medium. This result future indicates that the induction of p21 and pol eta depends on the 
activation status of IGF-1 in human keratinocytes in vitro at relatively modest does of 
UVB radiation that does not cause significant cell death.   
 To determine the optimal time for looking for the induction of p21 and pol eta 
proteins, the expression of p21 and pol eta was monitored at different time points (0, 12, 
24, 36, 48 hours)  after exposure to a single dose of UVB (100 J/m2 ) dose of UVB. The 
pol eta level began to rise at around 6 hours and continue to increase until 48 hours when 
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it reached, the maximal induction in control cells containing IGF-1 in culture medium. In 
contrast, when the cells were grown in the medium without IGF-1, the induction of pol 
eta was significantly less induced and independent on the time of harvest compared to the 
induction on the medium with IGF-1. Furthermore, the induction of p21 was investigated 
at different periods of time after treatment, the expression of p21 was high at 36 hours 
after treatment in medium with IGF-1. The induction of p21 increased gradually until 36 
hours after that the p21 protein levels began to decrease. On the other hand, when IGF-1 
was removed from the medium, the induction of p21 was less compared to the medium 
with IGF-1, which means the IGF-1 effect in the induction of p21 and the induction of 
p21 is dependent on time and IGF-1. These experiments examining the time- and UVB 
dose-dependence of p21 and pol eta induction further indicate that p53 signaling is 
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Figure 11. UVB dose- and time-dependent induction of p21 and pol eta in UVB-
irradiated N-TERTs is impacted by IGF-1 status. (A) N-TERT keratinocytes grown 
for 24 hr with or without IGF-1 were exposed to the indicated dose of UVB radiation. 
Cells were harvested 24 hr later and analyzed by western blotting with antibodies against 
pol eta, p21, and actin. (B) The graphs represent quantitation (average and SEM) of three 
or more independent experiments performed as in (A). (C) Kinetics of induction of p53 
target genes pol eta and p21. N-TERT cells were treated with UVB and harvested at 
different time (0, 12, 24, 36, 48 hr) later and analyzed by western blotting with antibodies 
against pol eta, p21, and actin. (D) The graphs represent quantitation (average and SEM) 
of three or more independent experiments performed as in (C).   
 
 
IGF-1 receptor antagonism disrupts the UVB-dependent induction of p21 and pol 
eta in keratinocytes in vitro 
 To evaluate the UVB dependent expression of p21 and pol eta depends on IGF-1, 
N-TERT cells were treated with vehicle (DMSO) or AG538 (IGF-1R inhibitor), 
incubated for 30 mins at 370C, and then exposed to 100 J/m2 dose of UVB. Cells were 
harvested 24 hours later for western blot analysis of protein levels. The results show that 
the AG538 inhibits the induction of p21 and pol eta proteins, which further confirms that 
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the expression of p21 and pol eta depends on the activation status of IGF-1R in 
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Figure 12. IGF-1R antagonism disrupts the UVB-dependent induction of p21 and 
























































IGF-1 and then the medium was changed to medium with DMSO or the IGF-1R inhibitor 
for 30 mins, after with the cells were exposed to 100 J/m2 UVB radiation. Cells were 
harvested 24 hr later and analyzed by western blotting with antibodies against pol eta, 
p21, and actin. (B) The graphs represent quantitation (average and SEM) of three or more 
independent experiments performed as in (A). 
 
 
IGF-1 receptor antagonism disrupts the UVB-dependent induction of p21 and pol 
eta mRNA and protein induction in human skin epidermis ex vivo 
To extend these findings to human skin, surgically discarded skin samples were 
used as an ex vivo model system to examine p21 and pol eta gene induction following 
UVB exposure. The skin from donors under the age of 60 was treated topically with 
vehicle (DMSO) or AG538 (20 μM) 30 mins before exposure to 800 J/m2 of UVB. 
Epidermis was isolated 24 hour later for harvesting protein and RNA for western blot and 
Q-PCR analyses, respectively. As shown in (Figure 14A), the mRNA levels of both p21 
and pol eta were increased by 2.5-3.5-fold in the control (DMSO-treated) skin following 
UVB exposure. In contrast, the genes failed to become induced by UVB exposure when 
the skin was treated with the IGF-1R inhibitor AG538. The primary data for these studies 
is provided in (Table 4), which includes as analysis of one skin sample from a donor over 
the age of 60. As shown in (Table 4) a lower induction of pol eta and p21 was observed 
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in this subject in comparison to the younger subject, which may be due to the lower 
expression of IGF-1 in geriatric skin (67). These results show that the loss of IGF-1 
signaling disrupts the UVB-dependent induction of p21 and pol eta in human skin 
epidermis, which confirm and extends results obtained with keratinocytes in vitro.  
Western blotting of epidermal protein was next carried out to confirm the mRNA 
results. As shown in (Figure 14B), p21 protein was clearly elevated in control skin after 
exposure to UVB radiation. In contrast, the level of p21 protein did not increase in the 
AG538-treaated skin, thus validating the mRNA data shown in (Figure 14A). Due to 
either low expression or insufficient sensitivity of antibodies, we were unable to detect 
polymerase eta protein expression in human skin. Nonetheless, these results demonstrate 
that the p53 target genes p21 and pol eta are not properly induced following UVB 
exposure in either keratinocytes in vitro or human skin ex vivo when IGF-1 signaling is 
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Figure 13. IGF-1R antagonism disrupts the UVB-dependent induction of p21 and 
pol eta in skin epidermis ex vivo.  (A) Skin explants from donors were treated typically 
with DMSO or AG358 and incubated for 30 min before exposure to 800 J/m2 of UVB 
radiation. Alternatively, RNA was purified from total skin epidermis 24 hr after UVB 
exposure and analyzed by RT-qPCR for UVB-dependent fold changes in expression of 
the p53 target genes. Relative mRNA for pol eta and p21 (average and SEM) from 3 
different skin samples. The asterisk indicates a significant different for pol eta (p<0.0001) 
and for p21 (p<0.0008). (B) Discarded human abdominoplasty skin was treated topically 
with vehicle (DMSO) or 20 µM AG538 for 30 min before exposure to 700 J/m2 UVB. 
Epidermal protein was harvested 24 hr after UVB exposure. The samples were analyzed 
by western blotting with antibodies against p21, and actin. (C) Relative p21 protein level 









Table 4. Analysis of pol eta and p21 mRNA induction in human abdominoplasty skin 
samples treated with DMSO and AG538 (IGF-1 inhibitor) as a function of IGF-1R status   
 
 
The functional consequences of IGF-1 loss on keratinocyte responses to UVB 
radiation  
The failure to properly induce p21 and polymerase eta in keratinocytes lacking 
IGF-1 may result in poor outcome for the cells. Because p21 is expected to promote a G1 
phase cell cycle arrest, we first used flow cytometry to examine cell cycle distribution in 
N-TERTs grown in the absence or presence of IGF-1 and exposed to UVB radiation, and 
then stained with propidium iodide. As shown in (Figure 15) a similar cell cycle 
distribution was observed in non-irradiation N-TERTs grown with or without IGF-1. 
Interestingly, when cells were exposed to UVB radiation, an increased number of cells 
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moved into S phase 24 hours after UVB exposure. No effect of IGF-1 withdrawal was 
observed on this effect, which suggests that the lack of IGF-1 does not significantly 




















Figure 14. Functional consequences of IGF-1 loss on keratinocyte responses to UVB 
radiation. N-TERT keratinocytes grown for three days with IGF-1then medium changed 
to with or without IGF-1 for 24 hr then exposed to the 100 J/m2 dose of UVB radiation. 
Cells were harvested 24 hr following UVB and then flow cytometry performed using 
propidium iodide staining was used to determine cell cycle distribution. This experiment 




Examination of markers of replication stress following additional UVB exposures  
Though the cell cycle analyses failed to indicate a significant effect of IGF-1 
withdrawal on progression through the cell cycle after UVB exposure, we next 
considered the possibility that the failure to induce the protective p21 and polymerase eta 
proteins may lead to defects in the response of the cells to a subsequent UVB exposure. 
Experiments were therefore carried out to look at replication stress markers in N-TERTs 
after the cells were exposed to second dose of UVB in the absence and presence of IGF-
1. The cells were grown for three days in normal medium and then the medium was 
changed to medium containing or lacking IGF-1. The cells were incubated for an 
additional 24 hours before exposure to the first dose of 100 J/m2 UVB. Twenty- four 
hours later, the cells were exposed to a second dose of 100 J/m2 of UVB and then 
harvested 6 hours later for analysis of replication stress responses. The replication stress 
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markers included PCNA mono-ubiquitination as an indicator for activation of the 
translesion synthesis pathway, chromatin-association of RPA as a marker of single-
stranded DNA generation, and phosphorylated Chk1 as a measure of ATR kinase 
signaling. All three markers of replication stress were moderately elevated in IGF-1-
deficient cells following the second UVB exposure (Figure 16A, B), which suggest that 
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Figure 15. Examination of markers of replication stress following additional UVB 
exposures. (A, B) N-TERT keratinocytes grown for 24 hr in the absence or presence of 
IGF-1 (10 ng/ml) and were then exposed to 100 J/m2 of UVB radiation. Then, the plates 
were incubated for 24 hr and exposed to 100 J/m2 of UVB radiation for a second time. 
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Cell lysates were prepared at 6 hr later and were analyzed by western blotting with 
antibodies against PCNA-ub, RPA, Chk-1, Chk-2, p53, total PCNA, total Chk-1 and 
actin. The western blot represents of three or more independent experiments performed.  
 
 
Furthermore, in cells lacking IGF-1 and exposed to a second dose of UVB, the 
expression of the p53 targets genes p21 and pol eta continued to be disrupted 24 hours 
after the second UVB exposure in comparison to the induction of p21 and pol eta that 
was increased in cells containing IGF-1 in the medium (Figure 17A, B). Because people 
are typically exposed to sunlight every day, these results suggests that IGF-1-deficiency 
may be associated with a chronic failure to induce p21 and pol eta, which may increase 
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Figure 16. Examination the impact of double doses of UVB in the induction of p53 
target genes. (A) N-TERT keratinocytes grown for 24 hr in the absence or presence of 
IGF-1 (10 ng/ml) and were then exposed to 100 J/m2 of UVB radiation. Then, the plates 
were incubated for 24 and exposed to 100 J/m2 of UVB radiation for the second times. 
Cell lysates were prepared at 24 hr later and were analyzed by western blotting with 
antibodies against pol eta, p21, XPC, DDB2 and actin. (B) The graphs represent 





The functional consequences of IGF-1 loss on the survival of keratinocyte responses 
to UVB radiation  
To examine the impact of IGF-1 loss on keratinocyte survival after UVB 
exposure, the cells were treated as I described previously and then MTT assays were 
performed to monitor cell viability. The results show that there are significant differences 
between the cells grown with or without IGF-1, but there is a significant increase in 
survival with IGF-1 medium compared to the withdrawal of the IGF-1 from the medium 
76 
 
(Figure 17A). To further confirm the impact of IGF-1 loss on keratinocytes survival after 
UVB exposure, the cells were treated as I described above and then 10 μl of cells were 
mixed with 10 μl of trypan blue staining. The cells viability was measured by using the 
CountessTM II FL automated cell counter instrument (Figure 17B).   
 
 
Because the MTT assay results indicated that there is a significant difference in 
acute survival, we next carried out clonogenic survival assays which may be more 
sensitive to change in long-term cell viability. These results showed that the IGF-1 and 
UVB have increased the cells’ survival and that could be because the IGF-1 regulates the 
expression of p21 and pol eta and a double dose of UVB stimulate the IGF-1 to increase 
more of p21 and pol eta. On the other hand, in the absence of IGF-1, cells may undergo 







































































































Figure 17. The functional consequences of IGF-1 loss on the survival of keratinocyte 




















































or presence of IGF-1 (10 ng/ml) and were then exposed to 100 J/m2 of UVB radiation. 
Then, the palates were incubated for 24 and exposed to 100 J/m2 of UVB radiation a 
second time. Cells survival was analyzed by using MTT reagent and then measuring the 
absorption by using a Bio-Tek plate reader. (B) N-TERT keratinocytes grown for 24 hr in 
the absence or presence of IGF-1 (10 ng/ml), exposed to a single or second dose of 100 
J/m2 of UVB radiation and then 24 hours later cells were stained with trypan blue and 
analyzed on a CountessTM II FL automated cell counter instrument to determine cell 
viability. (C) N-TERT keratinocytes grown for 24 hr in the absence or presence of IGF-1 
(10 ng/ml) and were then exposed to 100 J/m2 of UVB radiation. Then, cells were 
counted and cultured a specific number of cells (200, 400, 800 cells) for forming 
colonies. The colonies were measured by staining with crystal violet and the number of 
colonies was counted. 
 
 
      To determine if the loss of IGF-1 increases the level mutagenesis induced by 
UVB exposure, HPRT assays were carried out in N-TERT keratinocytes grown in the 
absence or presence of IGF-1, and exposed to a single or double dose of 100 J/m2 and 
incubated to 24 or 48 hours. Two million cells were plated to two 10 cm plates, then the 
6-thinoguanine was added, and the resistant clones were counted after crystal violet 
staining. Unfortunately, no distinct colonies could be observed over the large number of 




The advancing aging process is compacted because multiple changes occur during 
this process in the human subject. One of the major changes in the human body during 
the advancing age is what occurs in the human skin. The human skin with advancing age 
losses its ability to produce a sufficient amount of IGF-1, which may negatively impact 
how keratinocytes respond to different stressors, including UVB-induced DNA damage.  
 To better understand the biological consequences of insufficient IGF-1, we have 
used different in vitro and ex vivo model systems to understand the response of normal 
human keratinocytes to UVB exposure in the presence and absence of IGF-1 signaling. 
Using these model systems, we have seen that the response of human keratinocytes to 
UVB-induced DNA damage was dependent on the level of IGF-1 and the activation 
status of the IGF-1R (67). When IGF-1Rs are not active, the response of keratinocytes to 
UVB irradiation has been shown to be altered, including a reduced rate of UVB 
photoproduct removal (67). This reduced rate of NER may necessitate a reliance on other 
DNA damage response pathways, and the tumor suppressor protein is known to play an 
important role in this response. Two p53 target genes that are relevant to the UVB 
response include p21 and pol eta, which are known to arrest the cells at G1 phase to 
provide time for repair and bypass the photoproducts to avoiding any potential mutations 
that may drive tumor formation in the human skin. Moreover, we have seen that with loss 
of IGF-1, the IGF-1R in keratinocytes was not activated which could negatively impact 
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the activation of p53 target genes (pol eta and p21). The p53 target genes (pol eta and 
p21) in the keratinocytes may need to have activated IGF-1R. With a reduction in IGF-1 
levels, the IGF-1R is probably not activated, which could reduce the activation of p53 
target genes as we have seen with cultures in medium without IGF-1 (67)(68). The 
reduction in the activation of p53 targets genes is expected to lead to the stalling of 
replication forks and an increase in cells in the S phase with DNA damage, which leads 
to an increase in the potential of mutagenesis in the human keratinocytes. Furthermore, 
some articles have shown that losing IGF-1 leads to an increase in the cells’ apoptosis 
due to a decrease in the number of cells survival compared to cells grown in the IGF-1 
medium (62). Additionally, the keratinocytes may depend on IGF-1 to behave normally 
as was confirmed by one study. This study separated the growth factors and then added 
back to the medium with keratinocytes separately each time to monitor their impact on 
the cells death and behavior (62). This article has confirmed the role of IGF-1 in 
keratinocytes. Also, it gives the correlation between the geriatric people and NMSC.  
 To investigate whether IGF-1 impacts the induction of p53 target genes in the 
keratinocytes, we treated the cells with AG538 to look for the expression of p53 target 
genes. We can see clearly that the induction of p53 target genes (pol eta and p21) is 
increased in untreated cells, but with AG538, the induction of p53 target genes are 
decreased or less compared to the untreated cells. Our conclusion is that the IGF-1 plays 
a significant role in the induction of p53 target genes (pol eta and p21). Moreover, we see 
similar in vitro results with skin.      
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 The synergetic effect of losing IGF-1 in p53 is that the p53 depends on IGF-1 to 
activate because of the losing IGF-1 effect on the induction of p53. This effect on the 
induction of p53 plays a significant role in induction of p53 target genes (pol eta and 
p21). Additionally, some studies have shown that with a low level of IGF-1 induction the 
p53 was not activated and also with p53 inhibitor the p53 target genes were not properly 
induced (40)(68). That could be the reason why geriatric people is more prone to 
developing NMSC because p53 plays an important role in inhibiting the proliferation of 
cancer cells. To reduce the UVB induced carcinogenesis with the inactivation status of 
IGF-1R in geriatric people, reducing the risk factor of losing the IGF-1 can be achieved 
by activation of the dermal fibroblast to produce more IGF-1. Therefore, some clinical 
interventions for treating geriatric people, including FLR and microneedling device, may 
have great impact to restore the IGF-1 in the geriatric people and also activate the IGF-
1R for proper response to UVB induced DNA damage (19)(64). Moreover, we tried to 
inject IGF-1 into the human skin to restore the induction of p53 target genes in geriatric 
skin, but we did not see the expected result (Figure 22). These may be due to a number of 
factors, including in appropriate injection of the IGF-1 at the correct depth in the skin 
(deeper or more shallow) or not using sufficient amounts of IGF-1 component. We did 
not examine whether the injected IGF-1 had an effect on IGF-1 receptor activation, which 
may help to resolve this technical issue in the future. Moreover, there is a study about the 
FLR on reducing the population of the senescent fibroblast. FLR was done on people and 
it has a great outcome for reducing the population of senescent fibroblasts in older 
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people. That reason for losing of IGF-1 in older people is related to increase the 
population of senescent in geriatric people, the fibroblasts are responsible for producing 
the IGF-1 to activate the IGF-1R in keratinocytes (19). Reducing the population of 
senescent fibroblasts has had a positive impact to increase the induction of IGF-1 to 
activate the p53 targets genes to respond to UVB-induced DNA damaging in 
keratinocytes.  
 Furthermore, we investigated if the induction of p53 target genes (pol eta and 
p21) is UVB dose dependent. Busied on our results, we see clearly, that the p53 target 
genes are UVB dose dependent. Also, we see that the p53 influence by the activation 
status of IGF-1R and the induction of p53 increased after exposure to UVB meaning the 
induction of p53 is time dependent (68). We have been done experiments to test if the 
p53 target genes (pol eta and p21) are time dependent. We found that the induction of pol 
eta and p21 is time dependent with the high induction of pol eta seen at 48 hours and p21 
seen at 36 hours. From those results, we conclude that this reduction in IGF-1 expression 
impacts on activation of p53 and its regulation targets pol eta and p21. With advancing 
aging, the IGF-1 production reduces, which is the main risk for increasing the NMSC in 
older people. The opposite of this hypothesis would be that people with a high level of 
activation status for IGF-1R might have a high level of protection from UVB- induced 




The loss of IGF-1 impacts the expression of multiple gene products known to be 
regulated by p53 (p21 and pol eta) which may make the cells more dependent on TLS. 
We have tested the impact of losing IGF-1 on UVB exposure and tested the induction of 
PCNA mono-ubiquitination as an indicator for activation of the translesion synthesis 
pathway, phosphorylated Chk1 as measure of ATR kinase signaling, and chromatin-
association of RPA as a marker of single-stranded DNA generation. We have seen that all 
of those proteins increased in the absence of IGF-1 with UVB exposure. Therefore, the 
cells depended on the TLS to repair the photoproducts, which may make cells more error 
prone and promote the NMSC in the geriatric people. Moreover, we have tested the cells’ 
survival and we saw more cells survival in the medium with IGF-1 as compared with the 










In summary, we have shown that depriving keratinocytes of IGF-1 results in 
keratinocytes that are unable to induce the p53 target genes p21 and pol eta after UVB 
exposure, which may result in cells that are more prone to the mutagenic and lethal 
effects of UVB radiation. The failure to induce these gene products may be expected to 
lead to increased replication stress following UVB exposure. Consistent with this 
hypothesis, a significant increase in RPA70 enrichment on chromatin and PCNA mono-
ubiquitination were observed in UVB-irradiated cells lacking IGF-1. Moreover, with loss 
of IGF-1, there is reduced cell survival, which is due to the cells undergoing apoptosis 
because of decreased repair of DNA photoproducts.  
For future directions, we can test the effect of IGF-1 loss in human skin in vivo 
and compared these results to that by in vitro and ex vivo experiments looking for the 
response of keratinocytes to UVB induced DNA damage. This will be our third aim in 
this study, but we were waiting for the approval of IGF-1 drug and volunteer participants 
in this study. Another way to test the impact of losing IGF-1 in N-TERT keratinocytes is 
by culturing cells with IGF-1 for two days then changing to medium lacking IGF-1. The 
cells will be incubated for 1 day, then adding IGF-1 to the medium and incubated for 1-
hour exposure to UV light followed by incubation for 1 day. The cells will then lysed for 
western blot to see the induction of p53 target genes (pol eta and p21) as shown in 
(Figure 18). Moreover, testing the effect of chronic exposure in vitro (Figure 20), human 
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skin ex vivo, human skin in vivo, and human skin xenografts on mouse skin. For the 
human skin xenografts on mouse, the effect of chronic exposure that could give us 
significant information relevant to human health. Testing the role of FLR and 
dermabrasion on p53 targets genes and if they play a role in increased the induction of 
p21 and pol eta or not. Those future directions may have more significant data to show 
the effect of p21 and pol eta in NMSC in geriatric people. Moreover, the injection of 
IGF-1 to the epidermal layer to restore the IGF-1 to the epidermis layer could be one of 
the future directions with increased the function of IGF-1. I have been working in this 
experiment, but I get unexpected results that could be because of some procuring 
mistakes such as injected the IGF-1 to deep or other mistakes (Figure 21, Table 5). 
Moreover, we could look for expression of p53 target genes in the geriatric people after 
treating them with FLS and take biopsies from treated and untreated skin and test the 
expression of p53 target genes (pol eta and p21), or patient treated with microneedle and 
looking for p53 expression because those two methods increased the expression of IGF-1 
in geriatric people which could lead to increase the expression of p53 target genes in 







Figure 18. Design of an experiment to measure the induction of p53 target genes (pol eta 






















Figure 19. Design of an experiment to measure the impact of chronic exposure on cell 
survival.    
Cells grow for three days  
Change medium with or 
without IGF-1  
Exposure to multiple dose of 
UVB and 24 hours between 
each dose of UVB  







Figure 20. Chronic exposure to UVB increases cell death.  N-TERT keratinocytes 
grown for 24 hr in the absence or presence of IGF-1 (10 ng/ml) and were then exposed to 
multiple dose 100 J/m2 of UVB radiation. Then, the palates were incubated for 24 
between each UVB dose. The cells viability was analyzed by using MTT reagent and 
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Figure 21. Analysis of pol eta and p21 mRNA induction in human abdominoplasty 
skin samples injected with PBS and IGF-1 in skin epidermis ex vivo. Skin explants 
from geriatric donors were injected with PBS or IGF-1 and incubated for 30 min before 
exposure to 800 J/m2 of UVB radiation. RNA was purified from total skin epidermis 24 
hr after UVB exposure and analyzed by RT-qPCR for UVB-dependent fold changes in 
expression of the p53 target genes (pol eta and p21). Relative pol eta and p21 protein 




Table 5. Analysis of pol eta and p21 mRNA induction in human abdominoplasty skin 






NMSC – Nonmelanoma skin cancer  
BCC – Basal cell carcinoma  
SCC – Squamous cell carcinoma  
UV – Ultraviolet 
IGF-1 – Insulin-like growth factor-1 
No IGF-1 – Without insulin-like growth factor-1  
PBS – Phosphate-buffered saline   
IGF-1R – Insulin-like growth factor-1 receptor  
XPV – Xeroderma pigmentosum variant 
XPA – Xeroderma pigmentosum complementation group A 
XPB – Xeroderma pigmentosum complementation group B 
XPD – Xeroderma pigmentosum complementation group D 
XPC – Xeroderma pigmentosum complementation group C 
XPE – Xeroderma pigmentosum complementation group E 
XPF – Xeroderma pigmentosum complementation group F 
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XPG – Xeroderma pigmentosum complementation group G 
pol eta – polymerase eta  
FLR – Fractional laser resurfacing  
N-TERT – Telomerase-immortalized normal human foreskin keratinocytes 
P13k – Phosphoinositide 3-kinase  
AKT – Serine/threonine protein kinase   
p21 – Cyclin-dependent kinase inhibitor 1  
p53 – Tumor suppression protein  
DDB2 – DNA damage-binding protein 2  
CPD – Cyclobutene dimers  
6-4 PP – 6-4 Photoproducts  
ATR – Ataxia-telangiectasia mutated and Rad 3-related  
Chk1 – Checkpoint kinase 1  
Chk2- Checkpoint kinase 2  
DNA – De-oxy ribose nucleic acid  
IR – Ionizing radiation  
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NER – Nucleotide excision Repair  
PCNA – Proliferating cell nuclear antigen  
RPA – Replication protein A  
TLS – Translesion Synthesis  
UVA – Ultraviolet Radiation A  
UVB – Ultraviolet Radiation B  
UVC – Ultraviolet Radiation C  
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